Cancer Genome Interpreter (CGI) is an open platform designed to support the identification of tumor alterations that drive the disease and detect those that may be therapeutically actionable. In a Genome Medicine article, and in this blog, scientists behind the CGI provide insight into how it was developed and its benefits for researchers.
Monthly Archives: March 2018
World TB Day, which falls on March 24th each year, is organised by the World Health Organisation with the aim to raise public awareness of the devastating consequences of tuberculosis (TB) and the on-going efforts to end the global TB epidemic. To mark the occasion, we have discussed TB with Dr James Seddon, who has published a highly-accessed review about drug-resistant TB and advances in the treatment of childhood TB in our journal Pneumonia.
In October 2016, sixty-six international pilots and their teams came together to compete in the world’s first CYBATHLON, a championship for people with disabilities using advanced robotic assistive devices. Two days before, the scientific community met at the CYBATHLON Symposium to discuss recent progress and challenges in the field. Roger Gassert and Olivier Lambercy highlight the main insights from these events, which are further elaborated in a thematic series on the CYBATHLON, published in the Journal of NeuroEngineering and Rehabilitation.
A recently published thematic series in The Journal of Headache and Pain explores the most important aspects of a small molecule associated with migraine: Pituitary adenylate cyclase activating peptide (PACAP). The thematic series covers everything about PACAP from its discovery in the central nervous system to experimental studies with relevance to primary headaches. To find out more, we invited migraine researcher Song Guo to tell us the latest breakthroughs in migraine treatment.1
Last January, the Stand Up To Cancer (ST2C) charitable program announced the “Convergence 2.0” research initiative, which awards $11M to seven highly multidisciplinary teams in the field of cancer research. This research programme brings together life scientists, bioengineers and Microsoft machine learning experts to investigate new cancer therapies. David T. Ting, co-Editor-in-Chief of the journal Cancer Convergence, and member of one of these “Convergence” Dream Teams, talks about the significance and potential reach of the programme.
An article published today in Research Involvement and Engagement details how, in an international study looking at tinnitus treatments, researchers were able co-design the research with patient input, adding the voices of hundreds of experts with real life experience of the condition. Here, the authors explain the importance of patient and public involvement and how it benefits research.